August 26, 2020
The 2020 Abbreviated New Drug Application (ANDA) Litigation Intelligence Report
has recognized Kelley Drye as one of the top 50 Performing Law Firms representing defendants in Hatch-Waxman litigation.
The 2020 ANDA Litigation Intelligence Report
is the first Patexia report based on the activity and performance of attorneys and law firms for Hatch-Waxman litigation. Researchers analyzed the outcome of 976 ANDA cases filed by pharmaceutical companies from June 1, 2017, through June 1, 2020. Patexia is the largest network for intellectual property professionals with over 100,000 attorney profiles.